118 related articles for article (PubMed ID: 29893778)
21. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
[TBL] [Abstract][Full Text] [Related]
22. Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy.
Hansen J; Budäus L; Spethmann J; Schlomm T; Salomon G; Rink M; Haese A; Steuber T; Heinzer H; Huland H; Graefen M; Michl U
Urology; 2012 Oct; 80(4):877-82. PubMed ID: 22950996
[TBL] [Abstract][Full Text] [Related]
23. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
Mattei A; Würnschimmel C; Baumeister P; Hyseni A; Afferi L; Moschini M; Mordasini L; Grande P
Eur Urol; 2020 Sep; 78(3):424-431. PubMed ID: 32327264
[TBL] [Abstract][Full Text] [Related]
24. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract][Full Text] [Related]
25. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
[TBL] [Abstract][Full Text] [Related]
26. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
Briganti A; Chun FK; Salonia A; Gallina A; Zanni G; Scattoni V; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
Urology; 2007 Jan; 69(1):147-51. PubMed ID: 17270638
[TBL] [Abstract][Full Text] [Related]
27. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
28. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
29. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
30. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
[TBL] [Abstract][Full Text] [Related]
31. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
32. High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection.
Porcaro AB; Tafuri A; Sebben M; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Asian J Androl; 2020; 22(3):323-329. PubMed ID: 31347517
[TBL] [Abstract][Full Text] [Related]
33. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
35. Analysis of regional lymph nodes in periprostatic fat following robot-assisted radical prostatectomy.
Yuh B; Wu H; Ruel N; Wilson T
BJU Int; 2012 Feb; 109(4):603-7. PubMed ID: 21851536
[TBL] [Abstract][Full Text] [Related]
36. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
[TBL] [Abstract][Full Text] [Related]
37. What evidence do we need to support the use of extended pelvic lymph node dissection in prostate cancer?
Briganti A; Giannarini G; Karnes RJ; Gandaglia G; Ficarra V; Montorsi F
Eur Urol; 2015 Apr; 67(4):597-8. PubMed ID: 25281390
[No Abstract] [Full Text] [Related]
38. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
39. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.
von Bodman C; Godoy G; Chade DC; Cronin A; Tafe LJ; Fine SW; Laudone V; Scardino PT; Eastham JA
J Urol; 2010 Jul; 184(1):143-8. PubMed ID: 20478587
[TBL] [Abstract][Full Text] [Related]
40. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
